China Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon

Bulletin Express

06/26

China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.

The latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.

The transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.

The announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1143672213"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143672213\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143672213?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143672213","market":"us","top_or_hot":-1,"title":"China Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon","media":"Bulletin Express","content":"<p>China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.</p>\n<p>The latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.</p>\n<p>The transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.</p>\n<p>The announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Pharma finalises RMB2.00 billion third-tranche issuance of 2026 corporate bonds at 1.59% coupon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-26 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.</p>\n<p>The latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.</p>\n<p>The transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.</p>\n<p>The announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1143672213","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143672213","pubTimestamp":1782474198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"华润医药完成2026年第三期20.0亿元公司债券发行，票面利率为1.59%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"China Resources Pharmaceutical Group Limited (China Resources Pharma) has completed the public issuance of the third tranche of its 2026 corporate bonds through non-wholly-owned subsidiary China Resources Pharmaceutical Commercial Group Company Limited.\nThe latest tranche raised RMB2.00 billion with a three-year maturity and an annual coupon rate of 1.59%. Proceeds are earmarked for production-related expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investments, in accordance with relevant regulations.\nThe transaction follows two earlier tranches announced on 27 March 2026 and 28 April 2026, bringing the company closer to fulfilling its 2026 bond programme. The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.\nThe announcement was issued on 26 June 2026 and signed by Chairman Mr. Bai Xiaosong on behalf of the board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}